|
|
||||
 | ||||
|
|
St. Luke's autologous stem cell transplant program admits 400th patientSt. Luke's Medical Center has reached another milestone when by admitting the 400th patient to its Autologous Stem Cell Transplant (ASCT) Program. “We've seen an immense progression in transplant capabilities in our 14 years, and we will continue to further advance the science of transplant here at St. Luke's,” said Robert Taylor, MD, medical director and founder of the program. “Our goal continues to be excellence of care, and helping our patients to go home and be with their families,” said Jonathan S. Triesman, transplant physician with the program for eight years. Kristen Kemp, RN, BSN, has been the auto-stem cell transplant coordinator for 11 years. “We've done many research studies, seen side effects decrease, lengths of stay get shorter and outcomes improve. That's been exciting to see.” Higher doses of chemotherapy can often be curative for resistant tumors. Unfortunately, these doses are often associated with serious bone marrow damage. Now, by storing away healthy bone marrow before the high-dose chemotherapy, the desired results can be achieved without destroying the normal bone marrow. Since the bone marrow comes from the patient, it is always a "perfect match" and there is no need to look for a donor or wait for an unrelated donor to be found. This makes the procedure available to more people with more diseases and less toxicity. For more information about the ASCT program call 888-649-6892. St. Luke's provides the latest methods to treat cancer through treatment plans. Click here for more information about current treatment plans.
|
||
 |
||||
 |
 |
 |
 |
 |